Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

8.94
+0.69008.36%
Post-market: 8.940.00000.00%19:57 EDT
Volume:910.39K
Turnover:8.06M
Market Cap:615.18M
PE:-3.69
High:9.09
Open:8.32
Low:8.27
Close:8.25
Loading ...

EyePoint Pharmaceuticals Inc - Has $318 Million Cash Runway Into 2027

THOMSON REUTERS
·
07 May

EyePoint Pharmaceuticals Q1 Basic EPS USD -0.65

THOMSON REUTERS
·
07 May

EyePoint Pharmaceuticals Q1 Product Sales USD 715 Thousand

THOMSON REUTERS
·
07 May

EyePoint Pharmaceuticals Q1 Operating Expenses USD 73.29 Million

THOMSON REUTERS
·
07 May

EyePoint Pharmaceuticals Inc expected to post a loss of 66 cents a share - Earnings Preview

Reuters
·
05 May

EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025

GlobeNewswire
·
30 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
30 Apr

BRIEF-Eyepoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
16 Apr

EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
16 Apr

EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire
·
27 Mar

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
17 Mar

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
11 Mar

JonesTrading Remains a Buy on EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
08 Mar

EyePoint Pharma’s Earnings Call: Clinical Progress Amid Financial Challenges

TIPRANKS
·
07 Mar

EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
07 Mar

EyePoint Pharmaceuticals Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar

EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating

TIPRANKS
·
06 Mar

Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k

Simply Wall St.
·
06 Mar

Q4 2024 EyePoint Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
06 Mar

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ...

GuruFocus.com
·
06 Mar